Currently out of the existing stock ratings of Adam Maeder, 283 are a BUY (73.89%), 89 are a HOLD (23.24%), 11 are a SELL (2.87%).

Adam Maeder

Work Performance Price Targets & Ratings Chart

Analyst Adam Maeder, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 60.19% that have a potential upside of 34.03% achieved within 226 days.

Adam Maeder’s has documented 747 price targets and ratings displayed on 29 stocks. The coverage is on Healthcare, Consumer Cyclical, Financial Services, Technology sectors.

Most recent stock forecast was given on ABT, Abbott Laboratories at 22-Jun-2026.

Wall Street Analyst Adam Maeder

Analyst best performing recommendations are on RBOT (VICARIOUS SURGICAL).
The best stock recommendation documented was for RBOT (VICARIOUS SURGICAL) at 11/13/2024. The price target of $10.5 was fulfilled within 1 day with a profit of $1.35 (14.75%) receiving and performance score of 147.54.

Average potential price target upside

of $45.17 (25.22%) on INSP (INSPIRE MEDICAL SYSTEMS).
of $40.16 (15.7%) on ISRG (INTUITIVE SURGICAL).
of $36.75 on SI (SILVERGATE CAPITAL).

APEN Apollo Endosurgery AXNX Axonics Modulation Technologies EW Edwards Lifesciences Corp INSP Inspire Medical Systems ISRG Intuitive Surgical LIVN LivaNova PLC NVRO Nevro Corp SILK Silk Road Medical STIM Neuronetics STXS Stereotaxis SWAV Shockwave Medical TCMD Tactile Systems Technology XENT Intersect ENT NYXH Nyxoah ZYXI Zynex RBOT Vicarious Surgical NARI Inari Medical NSPR InspireMD ABT Abbott Laboratories M Macy’s RMD ResMed RXST Rxsight TMDI Titan Medical SGHT Sight Sciences AP Ampco-Pittsburgh AX Axos Financial SI Silvergate Capital STX Seagate Technology PLC SW Smurfit WestRock plc

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Joshua Jennings (TD COWEN)